ALBION FINANCIAL GROUP /UT – Bristol-Myers Squibb Company Transaction History
ALBION FINANCIAL GROUP /UT portfolio value:
$103,000
portfolio value
ALBION FINANCIAL GROUP /UT quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -21.85% | -404 shares | -39K | $71.09 | 1.44K |
| Q2 2022 | share | Increase | +0.05% | 1 shares | 7K | $77 | 1.84K |
| Q1 2022 | share | Increase | +0.05% | 1 shares | 20K | $73.03 | 1.84K |
| Q4 2021 | share | Decrease | -17.76% | -399 shares | -18K | $62.52 | 1.84K |
| Q3 2021 | share | 0.00% | 0 shares | -17K | $59.17 | 2.24K | |
| Q2 2021 | share | Increase | +0.09% | 2 shares | 11K | $65.79 | 2.24K |
| Q4 2020 | share | Increase | 0.00% | 2.24K shares | 139K | $60.6 | 2.24K |
| Q4 2018 | share | Decrease | -100.00% | -48.47K shares | -3.00M | $47.21 | 0 |
| Q3 2018 | share | Decrease | -5.89% | -3.03K shares | 158K | $56.02 | 48.47K |
| Q2 2018 | share | Increase | +0.46% | 235 shares | -392K | $49.59 | 51.50K |
| Q1 2018 | share | Decrease | -0.44% | -229 shares | 87K | $56.31 | 51.27K |
| Q4 2017 | share | Decrease | -0.56% | -289 shares | -145K | $54.21 | 51.50K |
| Q3 2017 | share | Increase | +117.32% | 27.96K shares | 1.97M | $56.04 | 51.79K |
| Q2 2017 | share | Decrease | -2.52% | -616 shares | -1K | $48.65 | 23.83K |
| Q1 2017 | share | Increase | +21.77% | 4.37K shares | 156K | $47.14 | 24.44K |
| Q4 2016 | share | Increase | +20.63% | 3.43K shares | 276K | $50.32 | 20.07K |
| Q3 2016 | share | Increase | +126.63% | 9.3K shares | 357K | $46.11 | 16.64K |
| Q2 2016 | share | Increase | +32.47% | 1.8K shares | 186K | $62.9 | 7.34K |
| Q1 2016 | share | Increase | +0.02% | 1 shares | -27K | $54.35 | 5.54K |